Sansure Biotech, Inc. engages in the research, development, production, and sales of diagnostic reagents and instruments. It also provides third-party medical testing services. The company's products include viral hepatitis, genital infection & genetics, pediatric infection, respiratory infection, nucleic acid blood screening, scientific research, public health, animal disease, nucleic acid extraction, and biochemical series reagents; automatic nucleic acid detection reaction system, and point-of-care testing mobile molecular diagnostic system series instrument; and fluorescence polymerase chain reaction assay software. Sansure Biotech was founded on April 23, 2008 and is headquartered in Changsha, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company